KNIGHT CAPITOL CONSULTANTS for GENZYME CORPORATION
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Senate consisderation of S. 1145, a bill to amend title 35, United States Code, to provide for patent reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | — |
Medicare/Medicaid MMM
S.2099: A bill to amend title XVIII of the Social Security Act to repeal the Medicare competitive bidding project for clinical laboratory services. Issues related to development of legislation to provide an update for physician payments under Medicare, including appropriate payment for clinical laboratory services.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | — |
Food Industry (safety, labeling, etc.) FOO
Development of legislation to ensure food safety, with associated provisions relating to pharmaceuticals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | — |
Pharmacy PHA
S.1695 : A bill to amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.